The Cannigma

JANUARY 13, 2023

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. The study called out pinene, myrcene, and beta-caryophyllene as specifically useful terpenes.

Terpenes 132

Terpenes Strains THC Treatment 132

The Cannigma

MAY 17, 2022

We also don’t know which, if any, terpenes have an effect on creativity. The best strains for creativity are Type II, with a balance of THC and CBD and a terpene profile that includes pinene, linalool, and beta-caryophyllene. A side effect of cannabis consumption is increased blood flow, particularly in the brain.

Terpenes 128

Terpenes Strains THC Oil 128

The Cannigma

DECEMBER 12, 2022

In time, Western civilization caught on, and consumption expanded around the globe. Responsible consumption is key, and in the case of psychedelics – where you could potentially become detached from reality – it’s important to be in a safe space, preferably around people you’re comfortable with.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Fig 1: Sucralose (In Study).

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

NOVEMBER 24, 2021

Research into the plant’s chemical compounds has also revealed a rich array of terpenes and flavonoids that may also account for the plant’s therapeutic effects (Kotsirilos and McGregor 2021 ). It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis.

Research and Development 52

Research and Development Medicine Access Media 52